Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-13 Option Award |
2025-02-24 6:58 pm |
N/A 2035-02-13 |
Mineralys Therapeutics Inc. | MLYS | Karydas Daphne Director |
32,900 | $0 | 32,900 (Direct) |
View |
| 2024-05-22 Option Award |
2024-05-23 4:21 pm |
N/A 2034-05-22 |
Mineralys Therapeutics Inc. | MLYS | Karydas Daphne Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2024-05-09 Option Award |
2024-05-13 06:44 am |
2025-05-09 2034-05-08 |
COMPASS Pathways plc | CMPS | Karydas Daphne Director |
26,000 | $0 | 26,000 (Direct) |
View |
| 2023-09-18 Option Award |
2023-09-20 6:58 pm |
2023-10-18 2033-09-17 |
COMPASS Pathways plc | CMPS | Karydas Daphne Director |
52,000 | $0 | 52,000 (Direct) |
View |
| 2023-09-13 Option Award |
2023-09-14 4:13 pm |
N/A 2033-09-13 |
Mineralys Therapeutics Inc. | MLYS | Karydas Daphne Director |
44,000 | $0 | 44,000 (Direct) |
View |
| 2022-06-17 Option Award |
2022-07-05 06:59 am |
N/A 2032-06-17 |
LogicBio Therapeutics Inc. | LOGC | Karydas Daphne Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-14 8:00 pm |
N/A 2031-06-11 |
LogicBio Therapeutics Inc. | LOGC | Karydas Daphne Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 4:22 pm |
N/A 2031-02-03 |
Syndax Pharmaceuticals Inc | SNDX | Karydas Daphne Chief Financial Officer |
95,000 | $0 | 95,000 (Direct) |
View |
| 2020-12-10 Option Award |
2020-12-14 4:46 pm |
N/A 2030-12-10 |
LogicBio Therapeutics Inc. | LOGC | Karydas Daphne Director |
20,000 | $0 | 20,000 (Direct) |
View |
Ownership |
2020-07-13 08:28 am |
N/A 2030-05-12 |
Syndax Pharmaceuticals Inc | SNDX | Karydas Daphne Chief Financial Officer |
0 | $0 | 215,000 (Direct) |
View |